Free Trial

Orthofix Medical Q4 2022 Earnings Report

Orthofix Medical logo
$17.43 +0.24 (+1.40%)
(As of 12/20/2024 05:16 PM ET)

Orthofix Medical EPS Results

Actual EPS
$0.19
Consensus EPS
-$0.37
Beat/Miss
Beat by +$0.56
One Year Ago EPS
$0.27

Orthofix Medical Revenue Results

Actual Revenue
$122.23 million
Expected Revenue
$121.90 million
Beat/Miss
Beat by +$330.00 thousand
YoY Revenue Growth
N/A

Orthofix Medical Announcement Details

Quarter
Q4 2022
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

Orthofix Medical Earnings Headlines

Orthofix to Participate in Upcoming Investor Conferences
Your chance to get on the next “60-Second Trade”
Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!
Orthofix price target raised to $22 from $20 at Roth MKM
See More Orthofix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Orthofix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orthofix Medical and other key companies, straight to your email.

About Orthofix Medical

Orthofix Medical (NASDAQ:OFIX) operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

View Orthofix Medical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings